Methods of suppressing, treating, or preventing graft rejection with an antibody or a portion thereof that binds to AILIM
US7438905B2 · kind B2 · utility
14Cited by
9References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2004 |
| Grant date | Oct 21, 2008 |
| Priority date | — |
| Expiry date | Oct 22, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Graft rejection is a serious problem associated with tissue or organ transplantation (e.g., allotransplantation or xenotransplantation), performed to treat various organ failures (e.g., liver, heart, lung, kidney, or pancreas). Described are pharmaceutical compositions for suppressing, treating, or preventing graft rejection comprising a substance having an activity to modulate signal transduction mediated by AILIM, and a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.